StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.56−0.19 (-0.38%)

Close on Nov 18, 2026Market cap $10.75BP/E 25.5Yield 0.50%

Qiagen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Qiagen's market cap was $11.01B on Nov 11, 2026, against $11.29B a year earlier. Over the last 5 years it ranged from $7.57B to $13.70B, with a median of $10.84B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.01B+3.5%
2025Dec 31, 2025$10.64B+3.6%
2024Dec 31, 2024$10.27B-2.4%
2023Dec 29, 2023$10.52B-13.6%
2022Dec 30, 2022$12.18B-11.1%
2021Dec 31, 2021$13.70B+8.6%
2020Dec 31, 2020$12.62B+51.9%
2019Dec 31, 2019$8.31B-1.7%
2018Dec 31, 2018$8.45B+8.6%
2017Dec 29, 2017$7.78B+10.6%
2016Dec 30, 2016$7.04B-0.4%
2015Dec 31, 2015$7.07B+18.2%
2014Dec 31, 2014$5.98B+0.9%
2013Dec 31, 2013$5.93B+32.4%
2012Dec 31, 2012$4.48B+131954.1%
2011Dec 30, 2011$3.39M-99.9%
2010Dec 31, 2010$4.78B-0.5%
2009Dec 31, 2009$4.80B–

More Qiagen figures

See a number that looks wrong?